Roivant Sciences Ltd

Company Snapshot
11-12 St. James’s Square
London, SW1Y 4LB
United Kingdom
Sector: Healthcare
Industry: Biotechnology
Full Time Employees:
Please select from the dropdown
Company Financials

2021
2022
Gross Profit
$21,738,000
$46,320,000
Operating Income
($474,766,000)
($1,211,748,000)
Net Income
($809,234,000)
($845,262,000)
2021
Gross Profit
$21,738,000
Operating Income
($474,766,000)
Net Income
($809,234,000)
2022
Gross Profit
$46,320,000
Operating Income
($1,211,748,000)
Net Income
($845,262,000)
The above data on Roivant Sciences Ltd came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Chairman of the Board
$150,000
$11,737,023
$1,105,198
$12,992,221
$12,992,221
Chairman of the Board
Independent Director
$125,000
$0
$0
$125,000
$125,000
Independent Director
Independent Director
$28,750
$0
$0
$28,750
$28,750
Independent Director
Independent Director
$27,500
$0
$0
$27,500
$27,500
Independent Director
Independent Director
$11,250
$0
$0
$11,250
Independent Director
Roivant Sciences Ltd listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us